Tsumura & Co. (FRA:TSUA)

Germany · Delayed Price · Currency is EUR

19.10

+0.10 (0.53%)

Last updated: Jun 26, 2026, 3:25 PM CET

-15.11% (1Y)

Market Cap	1.50B -4.6%
Revenue (ttm)	1.05B +6.4%
Net Income	153.37M -13.3%
EPS	2.05 -11.9%
Shares Out	n/a
PE Ratio	9.76
Forward PE	n/a
Dividend	68.43 (360.15%)
Ex-Dividend Date	Mar 30, 2026

Volume	n/a
Open	19.10
Previous Close	19.00
Day's Range	19.10 - 19.10
52-Week Range	18.00 - 23.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 6, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan. [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1893

Employees 4,272

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol TSUA

Financial Performance

In fiscal year 2026, Tsumura & Co.'s revenue was 192.62 billion, an increase of 6.36% compared to the previous year's 181.09 billion. Earnings were 28.12 billion, a decrease of -13.29%.

Financial numbers in JPY Financial Statements